Gavin Morgan
Gavin shares how using Speed to PatientTM supported cross-border drug supply during the COVID-19 pandemic.
Crystal Smith
Crystal talks about PCI's Speed to Patient offering and how it helped with a global orphan drug study.
FEATURES
The PCI WayTM - implementing Direct to Patient protocols: delivering life-changing therapies to those who need it most, anywhere in the world
“Accelerate your clinical trial distribution by leveraging PCI’s Speed to PatientTM solution.”
Kim Johnson-Cavanaugh
Director, Clinical Project Management
"Because patients are assured of potential time and cost-savings as well as additional conveniences when participating in Direct-to-Patient clinical trials versus traditional studies, use of the model has increased patient recruitment by up to 60 percent and helped maintain patient retention at over 95 percent."
BENEFITS